Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

24065-33-6Rivaroxaban EP Impurity F

● Auf Lager

Katalog-Nr.::	VE007629
CAS-Nr.::	24065-33-6
Summenformel::	C5H3ClO2S
Molare Masse::	162.59 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 24065-33-6

Parent drug

Rivaroxaban

IUPAC-Name

5-Chlorothiophene-2-carboxylic acid

Pharmakopöe-Synonyme

N/A

Other Synonyms

Rivaroxaban CTCA Impurity; 5-Chloro-2-thiophenecarboxylic acid; 2-Thiophenecarboxylic acid, 5-chloro-; 5-Chloro thiophene-2-carboxylic acid; 5-chloro-2-thiophenecarboxylicacid; 5-Chlorothiophene-2-carboxylicacid; Rivaroxaban metabolite M13; 5-chlorothiophenecarboxylic acid;

SMILES

O=C(C1=CC=C(Cl)S1)O

InChI

InChI=1S/C5H3ClO2S/c6-4-2-1-3(9-4)5(7)8/h1-2H,(H,7,8)

Shipping Condition

Ambient Temperature

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Beschreibung

Also known as Rivaroxaban CTCA Impurity or 5-chlorothiophene-2-carboxylic acid, it is an associate degree impurity of Rivaroxaban. Rivaroxaban is utilized to treat deep vein occlusion. a condition within which harmful blood clots kind within the blood vessels of the legs.